mitomycins - CISMeF

Preferred Label : mitomycins;

MeSH definition : A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.;

Wikipedia automatic translation : Mitomycin C;

MeSH annotation : MITOMYCIN is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Mitomycin C;

Is substance : O;

Détails

Origin ID

D008937;

UMLS CUI

C0026254;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Mitomycin Antineoplastic Antibiotic [NCIt concept]
MeSH Descriptor(s) used for indexing
- mitomycin [MeSH Descriptor]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
Record concept(s)
- mitomycins [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1 alpha-(4-(N-succinimidoxycarbonyl)butyryl)mitomycin C [MeSH Supplementary Concept]
- 1,10-bisacetoxymitosene WV15 [MeSH Supplementary Concept]
- 1-hydroxy-2,7-diaminomitosene [MeSH Supplementary Concept]
- 10-decarbamoylmitomycin C [MeSH Supplementary Concept]
- 10-decarbamoylmitomycin C-N(2)-deoxyguanosine-adduct [MeSH Supplementary Concept]
- 10-decarbamoyloxy-9-dehydromitomycin B [MeSH Supplementary Concept]
- 1a-(4-(3-benzoyloxy-1,3,5(10)-estratrien-17-yloxycarbonyl)butyryl)mitomycin C [MeSH Supplementary Concept]
- 1a-(4-(3-hydroxy-1,3,5(10)-estratrien-17-yloxycarbonyl)butyryl)mitomycin C [MeSH Supplementary Concept]
- 1a-acetylmitomycin C [MeSH Supplementary Concept]
- 1a-demethylmitomycin G [MeSH Supplementary Concept]
- 1a-docosahexaenoyl mitomycin C [MeSH Supplementary Concept]
- 2,3-(distearoyloxy)propane-1-dithio-4'-benzyloxycarbonyl-mitomycin C [MeSH Supplementary Concept]
- 2,7-diaminomitosene [MeSH Supplementary Concept]
- 3M protocol [MeSH Supplementary Concept]
- 6-demethyl-6-formylmitomycin C [MeSH Supplementary Concept]
- 7-(2-hydroxyethoxy)mitosane [MeSH Supplementary Concept]
- 7-N,7'-N'-(1'',2''-dithiepanyl-3'',7''-dimethylenyl)bismitomycin C [MeSH Supplementary Concept]
- 7-N,7'-N'-(1',2'-dithianyl-3',6'-dimethylenyl)bismitomycin C [MeSH Supplementary Concept]
- 7-N,7'-N'-(1',2'-dithiocanyl-3',8'-dimethylenyl)bismitomycin C [MeSH Supplementary Concept]
- 7-N,7'-N'-(2'',6''-dihydroxy-1'',7''-heptanediyl)bismitomycin C [MeSH Supplementary Concept]
- 7-N-(4-O-glucopyranosyl)phenyl-9-methoxymitosane [MeSH Supplementary Concept]
- 7-N-(4-O-sialosylphenyl)-9-methoxymitosane methyl ester [MeSH Supplementary Concept]
- 7-N-(4-hydroxyphenyl)mitomycin C [MeSH Supplementary Concept]
- 7-N-(N',N'-dimethylaminomethylene)aminoporfiromycin [MeSH Supplementary Concept]
- 7-N-(mercaptoethyl)mitomycin C [MeSH Supplementary Concept]
- 7-amino-10-decarbamoyloxy-9-dehydro-7-demethoxymitomycin B [MeSH Supplementary Concept]
- 7-cysteaminomitosane [MeSH Supplementary Concept]
- 7-methoxy-1-(N-pyrrolidino)mitosene [MeSH Supplementary Concept]
- ADM protocol [MeSH Supplementary Concept]
- BAFMi protocol [MeSH Supplementary Concept]
- DEB-M protocol [MeSH Supplementary Concept]
- EMV protocol [MeSH Supplementary Concept]
- FAMMe protocol [MeSH Supplementary Concept]
- FAMP protocol [MeSH Supplementary Concept]
- FMB protocol [MeSH Supplementary Concept]
- FOM protocol [MeSH Supplementary Concept]
- FR 66973 [MeSH Supplementary Concept]
- FSM protocol [MeSH Supplementary Concept]
- FuMi protocol [MeSH Supplementary Concept]
- KW 2149 [MeSH Supplementary Concept]
- MC 62 [MeSH Supplementary Concept]
- MC 77 [MeSH Supplementary Concept]
- MCF protocol [MeSH Supplementary Concept]
- MME protocol [MeSH Supplementary Concept]
- MQF-OK-UFT protocol [MeSH Supplementary Concept]
- MTF protocol [MeSH Supplementary Concept]
- MV protocol [MeSH Supplementary Concept]
- MVP protocol 2 [MeSH Supplementary Concept]
- N(6)-((dimethylamino)methylene)mitomycin C [MeSH Supplementary Concept]
- N-7-(2-(nitrophenyldithio)ethyl)mitomycin C [MeSH Supplementary Concept]
- N-methylmitomycin A [MeSH Supplementary Concept]
- RM 49 [MeSH Supplementary Concept]
- VMMc protocol [MeSH Supplementary Concept]
- mitiromycin [MeSH Supplementary Concept]
- mitomycin A [MeSH Supplementary Concept]
- mitomycin D [MeSH Supplementary Concept]
- mitomycin phosphate [MeSH Supplementary Concept]
- mitosane [MeSH Supplementary Concept]
- mitosene [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- mitomycin [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing mitomycin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Mitomycin Antineoplastic Antibiotic [NCIt concept]
Validated automatic mappings to BTNT
- Mitomycin [ICD-11 Extension code]
- Mitomycin [NCIt concept]
- Mitomycin (substance) [SNOMED CT concept]
- Mitomycin A [NCIt concept]
- mitomycin [SNOMED Notion]
- mitomycin [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients